Bio-Techne (TECH) Return on Capital Employed (2010 - 2026)
Bio-Techne's (TECH) quarterly Return on Capital Employed came in at 6.45% in Q1 2026, down 46.0% year-on-year from 11.95% in Q1 2025, and up 31.49% quarter-over-quarter from 4.91% in Q4 2025.
Bio-Techne (TECH) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bio-Techne's Return on Capital Employed history runs 17 years deep, the most recent figure standing at 6.45% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 46.0% year-over-year to 6.45% in Q1 2026; TTM through Mar 2026 was 6.45%, a 46.0% decrease from a year earlier, with the FY2025 full-year figure at 4.17%, down 406.0% from the prior year.
- Return on Capital Employed improved to 6.45% in Q1 2026 per TECH's latest filing, from 4.91% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 13.98% in Q2 2022 and bottomed at 4.22% in Q2 2025.
- The 5-year median for Return on Capital Employed is 9.91% (2024), against an average of 9.43%.
- Across the five-year window, Return on Capital Employed jumped 260 bps in 2022 and tumbled 422 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 13.25% in 2022, then fell by 22 bps to 10.3% in 2023, then fell by 24 bps to 7.88% in 2024, then tumbled by 38 bps to 4.91% in 2025, then jumped by 31 bps to 6.45% in 2026.
- Per Business Quant, the three latest TECH Return on Capital Employed figures stand at 6.45% (Q1 2026), 4.91% (Q4 2025), and 4.59% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 6.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45% |
| Dec 31, 2025 | 4.91% |
| Sep 30, 2025 | 4.59% |
| Jun 30, 2025 | 4.22% |
| Mar 31, 2025 | 6.91% |
| Dec 31, 2024 | 7.88% |
| Sep 30, 2024 | 7.40% |
| Jun 30, 2024 | 8.10% |
| Mar 31, 2024 | 9.91% |
| Dec 31, 2023 | 10.30% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | 12.00% |
| Mar 31, 2023 | 12.18% |
| Dec 31, 2022 | 13.25% |
| Sep 30, 2022 | 13.26% |
| Jun 30, 2022 | 13.98% |
| Mar 31, 2022 | 13.33% |
| Dec 31, 2021 | 12.32% |
| Sep 30, 2021 | 11.79% |
| Jun 30, 2021 | 11.74% |